{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:56:28Z","timestamp":1793854588161,"version":"4.6.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172268"],"award-info":[{"award-number":["82172268"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-024-00954-5","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T15:02:04Z","timestamp":1725116524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection"],"prefix":"10.1038","volume":"9","author":[{"given":"Dan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-8590","authenticated-orcid":false,"given":"Yanfeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2706-7806","authenticated-orcid":false,"given":"Gan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5658-2068","authenticated-orcid":false,"given":"Zengqin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5123-5537","authenticated-orcid":false,"given":"Haiyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,31]]},"reference":[{"key":"954_CR1","first-page":"265","volume":"48","author":"Centers for Disease Control and Prevention (CDC).","year":"1999","unstructured":"Centers for Disease Control and Prevention (CDC). Outbreak of Hendra-like virus--Malaysia and Singapore, 1998-1999. MMWR Morb. Mortal. Wkly Rep. 48, 265\u2013269 (1999).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"954_CR2","first-page":"335","volume":"48","author":"Centers for Disease Control and Prevention (CDC).","year":"1999","unstructured":"Centers for Disease Control and Prevention (CDC). Update: outbreak of Nipah virus--Malaysia and Singapore, 1999. MMWR Morb. Mortal. Wkly Rep. 48, 335\u2013337 (1999).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"954_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2010","volume":"29","author":"V Sharma","year":"2019","unstructured":"Sharma, V., Kaushik, S., Kumar, R., Yadav, J. P. & Kaushik, S. Emerging trends of Nipah virus: A review. Rev. Med Virol. 29, e2010 (2019).","journal-title":"Rev. Med Virol."},{"key":"954_CR4","doi-asserted-by":"crossref","unstructured":"Mishra, G., Prajapat, V. & Nayak, D. Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics. Immunology 171, 155\u2013169 (2024).","DOI":"10.1111\/imm.13695"},{"key":"954_CR5","doi-asserted-by":"crossref","unstructured":"Conroy, G. Nipah virus outbreak: what scientists know so far. Nature. https:\/\/www.nature.com\/articles\/d41586-023-02967-x (2023).","DOI":"10.1038\/d41586-023-02967-x"},{"key":"954_CR6","doi-asserted-by":"publisher","first-page":"105693","DOI":"10.1016\/j.micpath.2022.105693","volume":"170","author":"P Devnath","year":"2022","unstructured":"Devnath, P. et al. The pathogenesis of Nipah virus: A review. Micro. Pathog. 170, 105693 (2022).","journal-title":"Micro. Pathog."},{"key":"954_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.7861\/clinmed.2022-0166","volume":"22","author":"AM Alam","year":"2022","unstructured":"Alam, A. M. Nipah virus, an emerging zoonotic disease causing fatal encephalitis. Clin. Med. 22, 348\u2013352 (2022).","journal-title":"Clin. Med."},{"key":"954_CR8","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1126\/science.288.5470.1432","volume":"288","author":"KB Chua","year":"2000","unstructured":"Chua, K. B. et al. Nipah virus: a recently emergent deadly paramyxovirus. Science 288, 1432\u20131435 (2000).","journal-title":"Science"},{"key":"954_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002836","volume":"8","author":"GA Marsh","year":"2012","unstructured":"Marsh, G. A. et al. Cedar virus: a novel Henipavirus isolated from Australian bats. PLoS Pathog. 8, e1002836 (2012).","journal-title":"PLoS Pathog."},{"key":"954_CR10","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3201\/eid2006.131022","volume":"20","author":"Z Wu","year":"2014","unstructured":"Wu, Z. et al. Novel Henipa-like virus, Mojiang Paramyxovirus, in rats, China, 2012. Emerg. Infect. Dis. 20, 1064\u20131066 (2014).","journal-title":"Emerg. Infect. Dis."},{"key":"954_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJMc2202705","volume":"387","author":"XA Zhang","year":"2022","unstructured":"Zhang, X. A. et al. A Zoonotic Henipavirus in Febrile Patients in China. N. Engl. J. Med 387, 470\u2013472 (2022).","journal-title":"N. Engl. J. Med"},{"key":"954_CR12","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3201\/eid1110.050513","volume":"11","author":"BH Harcourt","year":"2005","unstructured":"Harcourt, B. H. et al. Genetic characterization of Nipah virus, Bangladesh, 2004. Emerg. Infect. Dis. 11, 1594\u20131597 (2005).","journal-title":"Emerg. Infect. Dis."},{"key":"954_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1286-4579(01)01384-3","volume":"3","author":"H Field","year":"2001","unstructured":"Field, H. et al. The natural history of Hendra and Nipah viruses. Microbes Infect. 3, 307\u2013314 (2001).","journal-title":"Microbes Infect."},{"key":"954_CR14","unstructured":"WHO. Nipah virus, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/nipah-virus (2018)."},{"key":"954_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nsmb.1435","volume":"15","author":"TA Bowden","year":"2008","unstructured":"Bowden, T. A. et al. Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. Nat. Struct. Mol. Biol. 15, 567\u2013572 (2008).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"954_CR16","doi-asserted-by":"publisher","first-page":"9953","DOI":"10.1073\/pnas.0804797105","volume":"105","author":"K Xu","year":"2008","unstructured":"Xu, K. et al. Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proc. Natl Acad. Sci. USA 105, 9953\u20139958 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"954_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003770","volume":"9","author":"Q Liu","year":"2013","unstructured":"Liu, Q. et al. Unraveling a three-step spatiotemporal mechanism of triggering of receptor-induced Nipah virus fusion and cell entry. PLoS Pathog. 9, e1003770 (2013).","journal-title":"PLoS Pathog."},{"key":"954_CR18","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1128\/JVI.02277-14","volume":"89","author":"Q Liu","year":"2015","unstructured":"Liu, Q. et al. Nipah virus attachment glycoprotein stalk C-terminal region links receptor binding to fusion triggering. J. Virol. 89, 1838\u20131850 (2015).","journal-title":"J. Virol."},{"key":"954_CR19","doi-asserted-by":"publisher","first-page":"e175461","DOI":"10.1172\/jci.insight.175461","volume":"8","author":"M Lu","year":"2023","unstructured":"Lu, M. et al. Vaccines based on the fusion protein consensus sequence protect Syrian hamsters from Nipah virus infection. JCI Insight 8, e175461 (2023).","journal-title":"JCI Insight"},{"key":"954_CR20","doi-asserted-by":"publisher","first-page":"146ra107","DOI":"10.1126\/scitranslmed.3004241","volume":"4","author":"KN Bossart","year":"2012","unstructured":"Bossart, K. N. et al. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge. Sci. Transl. Med. 4, 146ra107 (2012).","journal-title":"Sci. Transl. Med."},{"key":"954_CR21","doi-asserted-by":"publisher","first-page":"S493","DOI":"10.1093\/infdis\/jiz553","volume":"221","author":"MK Lo","year":"2020","unstructured":"Lo, M. K. et al. Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters. J. Infect. Dis. 221, S493\u2013s498 (2020).","journal-title":"J. Infect. Dis."},{"key":"954_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0023-7","volume":"2","author":"P Walpita","year":"2017","unstructured":"Walpita, P. et al. A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model. NPJ Vaccines 2, 21 (2017).","journal-title":"NPJ Vaccines"},{"key":"954_CR23","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3201\/eid2506.181620","volume":"25","author":"CE Mire","year":"2019","unstructured":"Mire, C. E. et al. Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease. Emerg. Infect. Dis. 25, 1144\u20131152 (2019).","journal-title":"Emerg. Infect. Dis."},{"key":"954_CR24","doi-asserted-by":"publisher","first-page":"e0007462","DOI":"10.1371\/journal.pntd.0007462","volume":"13","author":"N van Doremalen","year":"2019","unstructured":"van Doremalen, N. et al. A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters. PLoS Negl. Trop. Dis. 13, e0007462 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"954_CR25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2200065119","volume":"119","author":"SL Foster","year":"2022","unstructured":"Foster, S. L. et al. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease. Proc. Natl Acad. Sci. USA 119, e2200065119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"954_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00762-3","volume":"8","author":"M Lu","year":"2023","unstructured":"Lu, M. et al. Both chimpanzee adenovirus-vectored and DNA vaccines induced long-term immunity against Nipah virus infection. NPJ Vaccines 8, 170 (2023).","journal-title":"NPJ Vaccines"},{"key":"954_CR27","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1128\/JVI.00263-06","volume":"80","author":"HM Weingartl","year":"2006","unstructured":"Weingartl, H. M. et al. Recombinant nipah virus vaccines protect pigs against challenge. J. Virol. 80, 7929\u20137938 (2006).","journal-title":"J. Virol."},{"key":"954_CR28","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1128\/JVI.78.2.834-840.2004","volume":"78","author":"V Guillaume","year":"2004","unstructured":"Guillaume, V. et al. Nipah virus: vaccination and passive protection studies in a hamster model. J. Virol. 78, 834\u2013840 (2004).","journal-title":"J. Virol."},{"key":"954_CR29","doi-asserted-by":"publisher","first-page":"e164946","DOI":"10.1172\/JCI164946","volume":"133","author":"C Woolsey","year":"2023","unstructured":"Woolsey, C. et al. Recombinant vesicular stomatitis virus-vectored vaccine induces long-lasting immunity against Nipah virus disease. J. Clin. Invest. 133, e164946 (2023).","journal-title":"J. Clin. Invest."},{"key":"954_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jmb.2009.04.078","volume":"390","author":"KJ Cho","year":"2009","unstructured":"Cho, K. J. et al. The crystal structure of ferritin from Helicobacter pylori reveals unusual conformational changes for iron uptake. J. Mol. Biol. 390, 83\u201398 (2009).","journal-title":"J. Mol. Biol."},{"key":"954_CR31","doi-asserted-by":"publisher","first-page":"24514","DOI":"10.1021\/acsnano.3c07741","volume":"17","author":"X Gao","year":"2023","unstructured":"Gao, X. et al. Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases. ACS Nano 17, 24514\u201324538 (2023).","journal-title":"ACS Nano"},{"key":"954_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/14760584.2019.1578216","volume":"18","author":"HG Kelly","year":"2019","unstructured":"Kelly, H. G., Kent, S. J. & Wheatley, A. K. Immunological basis for enhanced immunity of nanoparticle vaccines. Expert Rev. Vaccines 18, 269\u2013280 (2019).","journal-title":"Expert Rev. Vaccines"},{"key":"954_CR33","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.abf6840","volume":"371","author":"AA Cohen","year":"2021","unstructured":"Cohen, A. A. et al. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice. Science 371, 735\u2013741 (2021).","journal-title":"Science"},{"key":"954_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41590-018-0305-x","volume":"20","author":"M Kanekiyo","year":"2019","unstructured":"Kanekiyo, M. et al. Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses. Nat. Immunol. 20, 362\u2013372 (2019).","journal-title":"Nat. Immunol."},{"key":"954_CR35","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12202","volume":"499","author":"M Kanekiyo","year":"2013","unstructured":"Kanekiyo, M. et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499, 102\u2013106 (2013).","journal-title":"Nature"},{"key":"954_CR36","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41586-021-03365-x","volume":"592","author":"S Boyoglu-Barnum","year":"2021","unstructured":"Boyoglu-Barnum, S. et al. Quadrivalent influenza nanoparticle vaccines induce broad protection. Nature 592, 623\u2013628 (2021).","journal-title":"Nature"},{"key":"954_CR37","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/j.chom.2023.09.011","volume":"31","author":"C Sun","year":"2023","unstructured":"Sun, C. et al. A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV. Cell Host Microbe 31, 1882\u20131897.e1810 (2023).","journal-title":"Cell Host Microbe"},{"key":"954_CR38","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","volume":"162","author":"M Kanekiyo","year":"2015","unstructured":"Kanekiyo, M. et al. Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site. Cell 162, 1090\u20131100 (2015).","journal-title":"Cell"},{"key":"954_CR39","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1021\/acsnano.0c08379","volume":"15","author":"YF Kang","year":"2021","unstructured":"Kang, Y. F. et al. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates. ACS Nano 15, 2738\u20132752 (2021).","journal-title":"ACS Nano"},{"key":"954_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41392-022-01041-8","volume":"7","author":"W Tai","year":"2022","unstructured":"Tai, W. et al. Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant. Signal Transduct. Target Ther. 7, 173 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"954_CR41","doi-asserted-by":"publisher","first-page":"eabi5735","DOI":"10.1126\/scitranslmed.abi5735","volume":"14","author":"MG Joyce","year":"2022","unstructured":"Joyce, M. G. et al. A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates. Sci. Transl. Med. 14, eabi5735 (2022).","journal-title":"Sci. Transl. Med."},{"key":"954_CR42","doi-asserted-by":"publisher","first-page":"5432","DOI":"10.1016\/j.cell.2021.09.015","volume":"184","author":"AC Walls","year":"2021","unstructured":"Walls, A. C. et al. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines. Cell 184, 5432\u20135447.e5416 (2021).","journal-title":"Cell"},{"key":"954_CR43","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.cell.2020.11.023","volume":"183","author":"J Dong","year":"2020","unstructured":"Dong, J. et al. Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein. Cell 183, 1536\u20131550.e1517 (2020).","journal-title":"Cell"},{"key":"954_CR44","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/infdis\/jiv449","volume":"213","author":"V Borisevich","year":"2016","unstructured":"Borisevich, V. et al. Escape From Monoclonal Antibody Neutralization Affects Henipavirus Fitness In Vitro and In Vivo. J. Infect. Dis. 213, 448\u2013455 (2016).","journal-title":"J. Infect. Dis."},{"key":"954_CR45","doi-asserted-by":"publisher","first-page":"407","DOI":"10.15252\/emmm.201505986","volume":"8","author":"P De Benedictis","year":"2016","unstructured":"De Benedictis, P. et al. Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis. EMBO Mol. Med. 8, 407\u2013421 (2016).","journal-title":"EMBO Mol. Med."},{"key":"954_CR46","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1038\/s41596-020-0394-5","volume":"15","author":"J Nie","year":"2020","unstructured":"Nie, J. et al. Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. Nat. Protoc. 15, 3699\u20133715 (2020).","journal-title":"Nat. Protoc."},{"key":"954_CR47","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1126\/science.abm5561","volume":"375","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Architecture and antigenicity of the Nipah virus attachment glycoprotein. Science 375, 1373\u20131378 (2022).","journal-title":"Science"},{"key":"954_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003684","volume":"9","author":"K Xu","year":"2013","unstructured":"Xu, K. et al. Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody. PLoS Pathog. 9, e1003684 (2013).","journal-title":"PLoS Pathog."},{"key":"954_CR49","doi-asserted-by":"publisher","first-page":"811157","DOI":"10.3389\/fmicb.2021.811157","volume":"12","author":"K Skowron","year":"2021","unstructured":"Skowron, K. et al. Nipah Virus-Another Threat From the World of Zoonotic Viruses. Front. Microbiol. 12, 811157 (2021).","journal-title":"Front. Microbiol."},{"key":"954_CR50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-0716-1892-9_8","volume":"2412","author":"FZ Firdaus","year":"2022","unstructured":"Firdaus, F. Z., Skwarczynski, M. & Toth, I. Developments in Vaccine Adjuvants. Methods Mol. Biol. 2412, 145\u2013178 (2022).","journal-title":"Methods Mol. Biol."},{"key":"954_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-6445-1_1","volume":"1494","author":"RR Shah","year":"2017","unstructured":"Shah, R. R., Hassett, K. J. & Brito, L. A. Overview of Vaccine Adjuvants: Introduction, History, and Current Status. Methods Mol. Biol. 1494, 1\u201313 (2017).","journal-title":"Methods Mol. Biol."},{"key":"954_CR52","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01868-23","volume":"14","author":"D Kim","year":"2023","unstructured":"Kim, D. et al. Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of Dabie bandavirus in aged ferrets. mBio 14, e0186823 (2023).","journal-title":"mBio"},{"key":"954_CR53","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.chom.2022.10.018","volume":"30","author":"PJM Brouwer","year":"2022","unstructured":"Brouwer, P. J. M. et al. Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection. Cell Host Microbe 30, 1759\u20131772.e1712 (2022).","journal-title":"Cell Host Microbe"},{"key":"954_CR54","doi-asserted-by":"publisher","first-page":"eabq0839","DOI":"10.1126\/science.abq0839","volume":"377","author":"AA Cohen","year":"2022","unstructured":"Cohen, A. A. et al. Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models. Science 377, eabq0839 (2022).","journal-title":"Science"},{"key":"954_CR55","doi-asserted-by":"publisher","first-page":"eaba6466","DOI":"10.1126\/sciimmunol.aba6466","volume":"5","author":"KA Swanson","year":"2020","unstructured":"Swanson, K. A. et al. A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain. Sci. Immunol. 5, eaba6466 (2020).","journal-title":"Sci. Immunol."},{"key":"954_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010573","volume":"18","author":"RJ Malonis","year":"2022","unstructured":"Malonis, R. J. et al. A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice. PLoS Pathog. 18, e1010573 (2022).","journal-title":"PLoS Pathog."},{"key":"954_CR57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0042-6822(82)90125-8","volume":"121","author":"L Lefrancios","year":"1982","unstructured":"Lefrancios, L. & Lyles, D. S. The interactionof antiody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Virology 121, 157\u2013167 (1982).","journal-title":"Virology"},{"key":"954_CR58","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/nprot.2016.102","volume":"11","author":"L von Boehmer","year":"2016","unstructured":"von Boehmer, L. et al. Sequencing and cloning of antigen-specific antibodies from mouse memory B cells. Nat. Protoc. 11, 1908\u20131923 (2016).","journal-title":"Nat. Protoc."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-00954-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-00954-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-00954-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T07:07:47Z","timestamp":1725260867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-00954-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["954"],"URL":"https:\/\/doi.org\/10.1038\/s41541-024-00954-5","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,31]]},"assertion":[{"value":"14 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}